ProfileGDS4718 / 239863_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 25% 61% 24% 35% 57% 58% 28% 32% 38% 38% 38% 37% 72% 58% 42% 40% 50% 57% 39% 21% 43% 36% 44% 33% 63% 39% 62% 38% 60% 49% 70% 25% 36% 41% 68% 53% 22% 26% 56% 35% 44% 40% 57% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9060338
GSM549102patient 115, normal, homogenized [OPG study]4.3421625
GSM549104patient 119, normal, homogenized [OPG study]6.1883661
GSM549108patient 138, normal, homogenized [OPG study]4.3478524
GSM549119patient 077, normal, homogenized [OPG study]4.7662435
GSM549133patient 032, cancer, homogenized [OPG study]5.9184257
GSM549139patient 042, cancer, homogenized [OPG study]5.9607358
GSM549099patient 107, normal, homogenized [OPG study]4.4625228
GSM549109patient 139, normal, homogenized [OPG study]4.6388932
GSM549110patient 046, normal, homogenized [OPG study]4.9123738
GSM549114patient 063, normal, homogenized [OPG study]4.844938
GSM549122patient 082, normal, homogenized [OPG study]4.9236838
GSM549134patient 033, cancer, homogenized [OPG study]4.8528437
GSM549136patient 036, cancer, homogenized [OPG study]7.085172
GSM549140patient 044, cancer, homogenized [OPG study]5.9531758
GSM549111patient 047, normal, homogenized [OPG study]5.0912942
GSM549113patient 057, normal, homogenized [OPG study]4.956940
GSM549132patient 031, cancer, homogenized [OPG study]5.5137450
GSM549137patient 038, cancer, homogenized [OPG study]5.9058557
GSM549142patient 047, cancer, homogenized [OPG study]5.0433339
GSM549100patient 110, normal, homogenized [OPG study]4.185621
GSM549107patient 135, normal, homogenized [OPG study]5.1108143
GSM549115patient 068, normal, homogenized [OPG study]4.7382936
GSM549116patient 072, normal, homogenized [OPG study]5.1634844
GSM549120patient 078, normal, homogenized [OPG study]4.6503433
GSM549131patient 030, cancer, homogenized [OPG study]6.3435563
GSM549118patient 074, normal, homogenized [OPG study]4.9620139
GSM549129patient 027, cancer, homogenized [OPG study]6.3043262
GSM549123patient 088, normal, homogenized [OPG study]4.8929438
GSM549124patient 006, cancer, homogenized [OPG study]6.1142460
GSM549126patient 015, cancer, homogenized [OPG study]5.4423449
GSM549128patient 025, cancer, homogenized [OPG study]6.983170
GSM549103patient 117, normal, homogenized [OPG study]4.3716425
GSM549117patient 073, normal, homogenized [OPG study]4.7616636
GSM549138patient 041, cancer, homogenized [OPG study]5.0336841
GSM549141patient 045, cancer, homogenized [OPG study]6.7824268
GSM549130patient 028, cancer, homogenized [OPG study]5.6909353
GSM549101patient 111, normal, homogenized [OPG study]4.2251922
GSM549105patient 128, normal, homogenized [OPG study]4.4166226
GSM549106patient 134, normal, homogenized [OPG study]5.8494656
GSM549112patient 048, normal, homogenized [OPG study]4.7696435
GSM549125patient 011, cancer, homogenized [OPG study]5.225944
GSM549127patient 024, cancer, homogenized [OPG study]4.9948140
GSM549135patient 035, cancer, homogenized [OPG study]5.8826857